Summit Therapeutics Pre-Tax Income 2015-2024 | SMMT

Summit Therapeutics pre-tax income for the twelve months ending September 30, 2024 was $-0.197B, a 67.09% decline year-over-year.

  • Summit Therapeutics annual pre-tax income for 2023 was $-0.615B, a 680.54% increase from 2022.
  • Summit Therapeutics annual pre-tax income for 2022 was $-0.079B, a 11.08% decline from 2021.
  • Summit Therapeutics annual pre-tax income for 2021 was $-0.089B, a 67.46% increase from 2020.

Summit Therapeutics Pre-Tax Income 2015-2024 | SMMT

  • Summit Therapeutics annual pre-tax income for 2023 was $-0.615B, a 680.54% increase from 2022.
  • Summit Therapeutics annual pre-tax income for 2022 was $-0.079B, a 11.08% decline from 2021.
  • Summit Therapeutics annual pre-tax income for 2021 was $-0.089B, a 67.46% increase from 2020.